Tuesday, 22 December 2020

Antibody-based Therapies Show Benefit in COVID Patients

Treatment with the monoclonal antibodies Casirivimab and Imdevimab seems most effective in COVID-19 patients who haven't yet elicited an immune response to the disease.


from Medindia Health News https://ift.tt/3pkxhpU

No comments:

Post a Comment